Long noncoding RNA-mediated activation of androgen receptor in prostate cancer

Asian Journal of Andrology

Volumn 16, Issue 3, 2014, Pages 418-419

  Petrovics, Gyorgy ^a   Srivastava, Shiv ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; LONG UNTRANSLATED RNA; MESSENGER RNA; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTOME;

AFRICAN AMERICAN; ARTICLE; CASTRATION RESISTANT PROSTATE CANCER; CHROMATIN; GENE ACTIVATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; HUMAN GENOME PROJECT; LNCAP CELL LINE; PCAT 1 GENE; PCGEM1 GENE; PRNCR1 GENE; PROSTATE CANCER; RNA PURIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; ANIMAL; GENETICS; MALE; METABOLISM; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; HUMANS; MALE; RECEPTORS, ANDROGEN; RNA, LONG NONCODING; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84900486126     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.126398     Document Type: Article

References (15)

1. Hieronymus H Sawyers CL. Traversing the genomic landscape of prostate cancer from diagnosis to death. Nat Genet 2012; 44: 613-4
2. Beltran H Rubin MA. New strategies in prostate cancer: Translating genomics into the clinic. Clin Cancer Res 2013; 19: 517-23
3. Dobi A Sreenath T Srivastava S Androgen Dependent oncogenic activation of ETS transcription factors by recurrent gene fusions in prostate cancer:Biological and clinical implications In: Wang Z editor. Androgen-responsive genes in prostate cancer. Springer: New York; 2013: P307-28
4. Nagano T Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011; 145: 178-81
5. Cheetham SW Gruhl F Mattick JS Dinger ME. Long noncoding RNAs and the genetics of cancer. Br J Cancer 2013; 108: 2419-25
6. Lanz RB McKenna NJ Onate SA Albrecht U Wong J et al. A steroid receptor coactivator SRA functions as an RNA and is present in an SRC-1 complex. Cell 1999; 97: 17-27
7. Bussemakers MJ van Bokhoven A Verhaegh GW Smit FP Karthaus HF et al. DD3: New prostate-specific gene highly overexpressed in prostate cancer. Cancer Res 1999; 59: 5975-9
8. Srikantan V Zou Z Petrovics G Xu L Augustus M et al. PCGEM1 a prostate-specific gene is overexpressed in prostate cancer. Proc Natl Acad Sci U S A 2000; 97: 12216-21
9. Prensner JR Iyer MK Balbin OA Dhanasekaran SM Cao Q et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1 an unannotated lincRNA implicated in Disease progression. Nat Biotechnol 2011; 29: 742-9
10. Chung S Nakagawa H Uemura M Piao L Ashikawa K et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 2011; 102: 245-52
11. Day JR Jost M Reynolds MA Groskopf J Rittenhouse H. PCA3: From basic molecular science to the clinical lab. Cancer Lett 2011; 301: 1-6
12. Crawford ED Rove KO Trabulsi EJ Qian J Drewnowska KP et al. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: Prospective study of 1962 cases. J Urol 2012; 188: 1726-31
13. Yang L Lin C Jin C Yang JC Tanasa B et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 2013; 500: 598-602
14. Petrovics G Zhang W Makarem M Street JP Connelly R et al. Elevated expression of PCGEM1 a prostate-specific gene with cell growth-promoting function is associated with high-risk prostate cancer patients. Oncogene 2004; 23: 605-11
15. Fu X Ravindranath L Tran N Petrovics G Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-Associated noncoding gene PCGEM1. DNA Cell Biol 2006; 25: 135-41.